Perbak Capital Partners’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Buy
+3,896
New +$1.08M 0.26% 40
2025
Q4
Sell
-1,432
Closed -$413K 240
2025
Q3
$413K Sell
1,432
-3,329
-70% -$985K 0.07% 248
2025
Q2
$1.57M Buy
+4,761
New +$1.53M 0.36% 38
2025
Q1
Sell
-2,051
Closed -$566K 195
2024
Q4
$566K Sell
2,051
-8,289
-80% -$2.64M 0.3% 53
2024
Q3
$3.58M Buy
10,340
+4,931
+91% +$1.7M 2.51% 8
2024
Q2
$1.79M Buy
+5,409
New +$1.87M 0.53% 42

Other funds holding CI

Perbak Capital Partners's CI Position: Q1 2026 in Review

Perbak Capital Partners opened a new position in Cigna (CI) in Q1 2026: 3,896 shares worth $1.04M. The stake represents 0.26% of the portfolio and ranks #40 among its holdings. This is a return to the name: Perbak Capital Partners previously reported a position in CI as recently as Q3 2025.

Perbak Capital Partners first reported a position in CI in Q2 2024 and has held it in 6 quarters since. The position peaked at $3.58M in Q3 2024. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Perbak Capital Partners held 3,896 shares of Cigna worth $1.04M as of Q1 2026.
  • Cigna was a new Perbak Capital Partners position in Q1 2026.
  • Cigna made up 0.26% of Perbak Capital Partners's portfolio in Q1 2026, its #40 holding.
  • Perbak Capital Partners first reported a position in Cigna in Q2 2024 and has held it in 6 quarters since.
  • Perbak Capital Partners's Cigna position peaked at $3.58M in Q3 2024.
  • 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Perbak Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.